]>
IRCT20180205038619N2 IRCT 2021-08-30 Iran University of Medical Sciences Evaluation of the effectiveness of TDCS (Transcranial Direct Current Stimulation) in the treatment of prolonged decreased of sense of smell in patients with Covid-19 Evaluation of the effectiveness of TDCS (Transcranial Direct Current Stimulation) in the treatment of hyposmia in patients with Covid-19 2021-09-10 anticipated 10 Complete https://irct.ir/trial/53545 interventional Randomization: N/A, Blinding: Not blinded, Placebo: Not used, Assignment: Single, Purpose: Treatment. N/A covid-19. The intervention group will receive a direct current of 2 mA for 20 minutes. In all patients, the anode electrode is located on the left DLPFC region and the cathode electrode is located on the right DLPFC region. The excitation current will be generated by a direct current generator with a maximum current of 4 mA (NeuroStim2 dual channel device). To transmit current, a 35 cm square electrode covered with 0.9% saline-impregnated sponge will be used.. Yes - There is a plan to make this available What will be shared: All the patient's data can be shared with privacy in regard to patients name When: Start accessing 6 months after publishing the results. To whom: For scholars working in academic centers Conditions: It can be analyzed and printed by other people by mentioning the source Where to obtain: Dr. Katayoun Moradi katayounmoradi69@gmail.com How to obtain: Upon authentication, data is provided to the individual. Comments:
public Katayoun Moradi
Department of Physical Medicine and Rehabilitation, Firuzgar Hospital, Valiasr Square, Tehran
Tehran Iran (Islamic Republic of) 1593747811 +98 21 8214 1229 katayounmoradi69@gmail.com Iran University of Medical Sciences scientific Katayoun Moradi
Department of Physical Medicine and Rehabilitation, Firuzgar Hospital, Valiasr Square, Tehran
Tehran Iran (Islamic Republic of) 1593747811 +98 21 8214 1229 katayounmoradi69@gmail.com Iran University of Medical Sciences Iran (Islamic Republic of) Age between 18 and 60 years Loss of sense of smell after Covid-19 (anosmia that has not improved for more than a month after the onset of symptoms and with routine treatment) Decreased of sense of smell after Covid-19 (anosmia that has not improved for more than a month after the onset of symptoms and with routine treatment) 18 years 60 years Both Pregnancy Seizures or family history of seizures Implanted metal devices such as pacemakers, metal plate and wire History of brain surgery B34.2 Coronavirus infection, unspecified Treatment - Other The intervention group will receive a direct current of 2 mA for 20 minutes. In all patients, the anode electrode is located on the left DLPFC region and the cathode electrode is located on the right DLPFC region. The excitation current will be generated by a direct current generator with a maximum current of 4 mA (NeuroStim2 dual channel device). To transmit current, a 35 cm square electrode covered with 0.9% saline-impregnated sponge will be used. Olfactory sensitivity. Timepoint: Patients are assessed before the intervention and one week after 4 sessions of TDCS. Method of measurement: Participants' olfactory sensitivity will be measured by the Smell Identification Test (SIT) . In this method, 24 Iranianized odor such as rose, caffeine, saffron, etc. will be used and a score of 24 will be given, with a score of 19 to 24 being considered the normal range. A score of 14 to 18 is mild microsmia, a score of 10 to 13 is severe microsmia, and a score of 0 to 9 is anosmia. Iran University of Medical Sciences Approved 2021-01-05 Ethics committee of Iran University of Medical Sciences Ethics committee, Iran University of Medical Sciences, Hemmat Highway, Tehran Tehran Tehran Iran (Islamic Republic of)